坦哥和物理治疗在帕金森病中的干预:一项试点研究对运动和认知能力的疗效结果
Giuseppe Rabini1, Claudia Meli2, Giulia Prodomi2
1Center for Mind/Brain Sciences-CIMeC, University of Trento, Corso Bettini 31, 38068, Rovereto, TN, Italy. giuseppe.rabini@unitn.it.
Scientific reports
|May 24, 2024
概括
像阿根廷坦哥和理疗等体力活动有助于稳定帕金森病 (PD) 患者的运动和认知功能. 坦哥独特地增强了面部情绪识别,这表明除了运动技能之外还有更广泛的好处.
科学领域:
- 神经科学是一个神经科学.
- 运动科学 运动科学
- 老年学是一门学科.
背景情况:
- 帕金森病 (PD) 的药理疗法对诸如认知障碍和姿势不稳定等非运动症状具有有限的疗效.
- 补充干预措施对于管理PD多方面的症状变得越来越重要.
- 身体活动被认为是PD管理策略的关键组成部分.
研究的目的:
- 调查阿根廷坦哥与基于小组的物理治疗对PD患者的运动和认知功能的影响.
- 在四个月的时间内,比较这两种不同的身体干预措施的疗效.
- 探索超越运动症状改善的潜在益处,特别是在认知和情绪领域.
主要方法:
- 一项试点纵向研究,涉及24名PD患者.
- 参与者被分配到一个适应的阿根廷探戈组或基于小组的物理治疗计划.
- 在为期四个月的干预期 (每周两次会议) 之前和之后,对运动技能和神经心理功能进行了评估.
主要成果:
- 这两种干预措施都导致了PD患者运动和认知能力的总体稳定.
- 在坦哥和物理治疗组中观察到静态和动态平衡的显著改善.
- 在行动命名任务中,两组人都注意到认知能力的改善;然而,只有坦哥组表现出增强的面部情绪识别能力.
结论:
- 身体活动在稳定和可能减缓帕金森病进展方面发挥着至关重要的作用.
- 基于小组的身体干预为PD患者提供了显著的好处.
- 适应的阿根廷探戈可以通过改善运动功能以外的非运动领域,如情绪识别,提供独特的优势.
相关概念视频
Parkinson's Disease: Treatment
261
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
261
Parkinson's Disease: Overview
528
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
528


